Judge Rejects 340B Provider Challenge to California Medicaid Drug Payment Shift

U.S. District Court Sacramento
A federal district judge in Sacramento, Calif., dismissed a lawsuit on July 17 aimed at reversing the state’s transfer of Medicaid managed care drugs benefits to Medicaid fee for service.
A federal district judge in Sacramento, Calif., recently dismissed a lawsuit aimed at reversing the state’s January 2022 transfer of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Commentary in NEJM Backs Making Hospitals Report Gross Profits from 340B

NEJM
To encourage nonprofit hospitals to do more for their communities, policymakers could examine how hospitals are using their gross profit from the 340B program, an opinion article in The New England Journal of Medicine says.
The 340B drug pricing program has evolved from a “buy low, sell low” program to help safety-net hospitals serve low-income [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Is “Off the Rails,” Civil Rights Leader Chavis Says in Nationally Syndicated Op-Ed

Benjamin Chavis
Health system greed has “made a mockery” of the 340B program, civil rights leader Benjamin Chavis says in nationally syndicated op-ed published by multiple African American news organizations.
Health system greed has “made a mockery” of the 340B drug pricing program and leads to practices that widen health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Medicare Part B Keeping Default Pay Rate for 340B Drugs, Says OPPS Proposed Rule

CMS
Medicare Part B plans to continue paying average sales price plus 6% for for 340B acquired drugs and biologicals in 2024, the U.S. Centers for Medicare & Medicaid Services said July 13.
Medicare Part B plans to continue paying the statutory default rate—generally average sales price plus 6%—for 340B acquired drugs and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. Chamber of Commerce Asks Court to Pause Medicare Drug Price Negotiations

U.S. Chamber of Commerce
The U.S. Chamber of Commerce asked a federal district court last week for a preliminary injunction against Medicare drug price negotiation.
The U.S. Chamber of Commerce asked a federal district court in Ohio last week to stop Medicare from implementing the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In What Could be a First, Drug Maker Gives Providers Deadline to Request 340B Overcharge Refunds

VistaPharm
Drug manufacturer VistaPharm says requests for refunds for 340B overcharges must be received before Aug. 31. No manufacturer is believed to have set such a deadline before, and it's unclear if VistaPharm is the first to say refunds are available upon request.
Generic and over-the-counter drug manufacturer VistaPharm said in a public notice this week that it has identified 340B covered entities [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

UPDATED: Contract Pharmacy Restrictions Cut $1.5 Billion in 340B Hospital Revenue, $8.4 Billion More Endangered, Report Says

340B Health study
Drug manufacturers' 340B contract pharmacy restrictions have pulled $8.4 billion out of the savings hospitals achieve using contract pharmacies to dispense 340B drugs, a new 340B Health study found.
Early, limited versions of contract pharmacy restrictions for 340B hospitals cut their revenue by $1.5 billion in one year, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Some 340B Hospitals Might Get Less Than Expected Under Fix for Illegal Medicare Drug Payment Cuts

Spreadsheet
CMS's projections of what it owes 340B hospitals for unlawful Medicare Part B drug payment cuts might not align with what health systems and hospitals expect to get.
A $9 billion Medicare proposal to repay 340B hospitals for unlawful Part B drug payment cuts includes a spreadsheet showing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Providers March to Capitol Hill for Second Straight Year to ‘Defend 340B’

CV340B
Around 50 340B provider advocates marched to the U.S. Capitol yesterday to urge Congress to defend the drug pricing program. Nonprofit group CV340B organized the demonstration.
On a sunny, humid, 92-degree afternoon in Washington, D.C., over 50 safety-net health care providers marched to the U.S. Capitol [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B PROVIDER LEADER SPOTLIGHT

Tiffany Taylor, Director of Compliance, Allies in Hope, Inc. and 2023 Scholarship Recipient for the Apexus Advanced 340B Operations Certificate Program

Tiffany Taylor

Q: Where did you go to college/graduate school?

I attended Southern Texas University, located in Houston, Texas. Go Tigers!

Q: Where do you live?

I currently live

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report